ML18165A074

07-11-18 Letter to the Honorable John Barrasso Et Al from Eugene Dacus, Informing Congress of Nrc'S Publishing of the Final Rule, Medical Use of Byproduct - Material - Medical Event Definitions, Training and Experience, and Clarifying Amend

ML18165A074
Person / Time
Issue date:	07/11/2018
From:	Eugene Dacus Office of Congressional Affairs
To:	Barrasso J, Capito S, Shimkus J, Upton F, Walden G US Congress, US HR (House of Representatives), US SEN (Senate)
Love-Blair A
Shared Package
ML18165A067	List: ML18165A074 ML18165A076
References
Download: ML18165A074 (6)

Text

July 11, 2018 The Honorable John Barrasso Chairman, Committee on Environment and Public Works United States Senate Washington, DC 20510

Dear Mr. Chairman:

The U.S. Nuclear Regulatory Commission (NRC) is publishing the following document in the Federal Register:

Title:

Medical Use of Byproduct Material - Medical Event Definitions, Training and Experience, and Clarifying Amendments [RIN 3150-AI63; NRC-2008-0175].

• Description of the document: The NRC is amending its regulations related to the medical use of byproduct material, which were last amended in 2002. Over the past 14 years, stakeholders members of the medical community have identified certain issues in implementing these regulations. As a result, the NRC is updating its regulations to address technological advances and changes in medical procedures, and enhance patient safety.

• Dates: The effective date of this final rule is 180 days after publication.

• This is not a major rule as defined by the Congressional Review Act.

For more information, see the enclosed document.

Please contact me at 301-415-1776 if you have questions or need more information.

Sincerely,

/RA/

Eugene Dacus, Director Office of Congressional Affairs

Enclosure:

Federal Register notice cc: Senator Thomas R. Carper

July 11, 2018 The Honorable Greg Walden Chairman, Committee on Energy and Commerce United States House of Representatives Washington, DC 20515

Dear Mr. Chairman:

The U.S. Nuclear Regulatory Commission is publishing the following document in the Federal Register:

Title:

Medical Use of Byproduct Material - Medical Event Definitions, Training and Experience, and Clarifying Amendments [RIN 3150-AI63; NRC-2008-0175].

• Description of the document: The NRC is amending its regulations related to the medical use of byproduct material, which were last amended in 2002. Over the past 14 years, stakeholders members of the medical community have identified certain issues in implementing these regulations. As a result, the NRC is updating its regulations to address technological advances and changes in medical procedures, and enhance patient safety.

• Dates: The effective date of this final rule is 180 days after publication.

• This is not a major rule as defined by the Congressional Review Act.

For more information, see the enclosed document.

Please contact me at 301-415-1776 if you have questions or need more information.

Sincerely,

/RA/

Eugene Dacus, Director Office of Congressional Affairs

Enclosure:

Federal Register notice cc: Representative Frank Pallone, Jr.

July 11, 2018 The Honorable Fred Upton Chairman, Subcommittee on Energy Committee on Energy and Commerce United States House of Representatives Washington, DC 20515

Dear Mr. Chairman:

The U.S. Nuclear Regulatory Commission is publishing the following document in the Federal Register:

Title:

Medical Use of Byproduct Material - Medical Event Definitions, Training and Experience, and Clarifying Amendments [RIN 3150-AI63; NRC-2008-0175].

• Description of the document: The NRC is amending its regulations related to the medical use of byproduct material, which were last amended in 2002. Over the past 14 years, stakeholders members of the medical community have identified certain issues in implementing these regulations. As a result, the NRC is updating its regulations to address technological advances and changes in medical procedures, and enhance patient safety.

• Dates: The effective date of this final rule is 180 days after publication.

• This is not a major rule as defined by the Congressional Review Act.

For more information, see the enclosed document.

Please contact me at 301-415-1776 if you have questions or need more information.

Sincerely,

/RA/

Eugene Dacus, Director Office of Congressional Affairs

Enclosure:

Federal Register notice cc: Representative Bobby L. Rush

July 11, 2018 The Honorable John Shimkus Chairman, Subcommittee on Environment Committee on Energy and Commerce United States House of Representatives Washington, DC 20515

Dear Mr. Chairman:

The U.S. Nuclear Regulatory Commission is publishing the following document in the Federal Register:

Title:

Medical Use of Byproduct Material - Medical Event Definitions, Training and Experience, and Clarifying Amendments [RIN 3150-AI63; NRC-2008-0175].

• Description of the document: The NRC is amending its regulations related to the medical use of byproduct material, which were last amended in 2002. Over the past 14 years, stakeholders members of the medical community have identified certain issues in implementing these regulations. As a result, the NRC is updating its regulations to address technological advances and changes in medical procedures, and enhance patient safety.

• Dates: The effective date of this final rule is 180 days after publication.

• This is not a major rule as defined by the Congressional Review Act.

For more information, see the enclosed document.

Please contact me at 301-415-1776 if you have questions or need more information.

Sincerely,

/RA/

Eugene Dacus, Director Office of Congressional Affairs

Enclosure:

Federal Register notice cc: Representative Paul Tonko

July 11, 2018 The Honorable Shelley Moore Capito Chairman, Subcommittee on Clean Air and Nuclear Safety Committee on Environment and Public Works United States Senate Washington, DC 20510

Dear Madam Chairwoman:

The U.S. Nuclear Regulatory Commission is publishing the following document in the Federal Register:

Title:

Medical Use of Byproduct Material - Medical Event Definitions, Training and Experience, and Clarifying Amendments [RIN 3150-AI63; NRC-2008-0175].

• Description of the document: The NRC is amending its regulations related to the medical use of byproduct material, which were last amended in 2002. Over the past 14 years, stakeholders members of the medical community have identified certain issues in implementing these regulations. As a result, the NRC is updating its regulations to address technological advances and changes in medical procedures, and enhance patient safety.

• Dates: The effective date of this final rule is 180 days after publication.

• This is not a major rule as defined by the Congressional Review Act.

For more information, see the enclosed document.

Please contact me at 301-415-1776 if you have questions or need more information.

Sincerely,

/RA/

Eugene Dacus, Director Office of Congressional Affairs

Enclosure:

Federal Register notice cc: Senator Sheldon Whitehouse

SUBJECT:

Congressional Letters informing Congress of the NRC's publishing the final rule, "Medical Use of Byproduct Material - Medical Event Definitions, Training and Experience, and Clarifying Amendments," in the Federal Register. Date: July 11, 2018 Identical letters sent to:

The Honorable John Barrasso with cc to Senator Thomas R. Carper The Honorable Shelley Moore Capito with cc to Senator Sheldon Whitehouse The Honorable Fred Upton with cc to Representative Bobby L. Rush The Honorable Greg Walden with cc to Representative Frank Pallone, Jr.

The Honorable John Shimkus with cc to Representative Paul Tonko DISTRIBUTION: RASB r/f ADAMS ACCESSION NO. ML OFC NMSS/DRM/MSRB NMSS/DRM/MSRB NMSS/DRM/RASB NMSS/DRM OCA NAME AloveBlair KMorganButler CBladey THolahan EDacus DATE 2/9/2018 I /18 I /18 I /18 07I11/18 OFFICIAL RECORD COPY